产品
编 号：F391006
分子式：C20H24N2O5
分子量：372.41
分子式：C20H24N2O5
分子量：372.41
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
1mg
询价
询价
5mg
询价
询价
结构图
CAS No: 56290-94-9
产品详情
生物活性：
Medroxalol (RMI81968) is an orally active adrenergic receptor antagonist, blocks α- and β-adrenergic receptors. Medroxalol shows antihypertensive and vasodilating effects.
体内研究：
Medroxalol (oral gavage; 12.5-50 mg/kg; once daily; 12 d) treatment shows antihypertensive activity in spontaneously hypertensive rats.Animal Model:Male spontaneously hypertensive rats (SHR)
Dosage:12.5, 25, or 50 mg/kg
Administration:Oral gavage; 12.5, 25, or 50 mg/kg; once daily; 12 days
Result:Produced a dose-related fall in blood pressure.
体外研究：
Medroxalol (0.1-10 μM; 20 min) shows α- and β-adrenergic receptor antagonism in isolated rabbit aortic strip.
Medroxalol (RMI81968) is an orally active adrenergic receptor antagonist, blocks α- and β-adrenergic receptors. Medroxalol shows antihypertensive and vasodilating effects.
体内研究：
Medroxalol (oral gavage; 12.5-50 mg/kg; once daily; 12 d) treatment shows antihypertensive activity in spontaneously hypertensive rats.Animal Model:Male spontaneously hypertensive rats (SHR)
Dosage:12.5, 25, or 50 mg/kg
Administration:Oral gavage; 12.5, 25, or 50 mg/kg; once daily; 12 days
Result:Produced a dose-related fall in blood pressure.
体外研究：
Medroxalol (0.1-10 μM; 20 min) shows α- and β-adrenergic receptor antagonism in isolated rabbit aortic strip.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备